Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition:   Asthma Interventions:   Drug: Montelukast;   Drug: Fluticasone Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition:   Asthma Intervention:   Device: RP - TA Sponsor:   Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials